C. Light Technologies raises $2.5M seed round to commercialize first ever retinal eye-tracking device for neurodegenerative disease
C. Light Technologies raises $2.5M seed round to commercialize first ever retinal eye-tracking device for neurodegenerative disease Share Article Creative Ventures leads the funding round, with participation from Yamaha Motor Ventures. "We take pride in being on the forefront of innovation and look forward to reshaping the neurodegenerative landscape using our non-invasive, cost effective solutions," said Dr. Christy K. Sheehy, P.h.D., C. Light Technologies’ Co-Founder and CEO. BERKELEY, Calif. (PRWEB) February 02, 2021 C. Lig...
Source: prweb.com